Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Zantac and ranitidine are routinely used by millions of heartburn sufferers. So how did the drug become a cancer risk?

Since the FDA first warned that ranitidine products may contain a potentially cancer-causing impurity, known as N-nitrosodimethylamine, numerous drugmakers have recalled their ranitidine products ...

CVS and Walgreens quit selling heartburn drug Zantac and generic ranitidine products during an ongoing FDA investigation into possible cancer risks.

People who are taking over-the-counter ranitidine should consider taking one of several other heartburn drugs that are available.

Although several studies did find that taking ranitidine could increase the concentration of nitrites in the stomach—and at least one found a statistically significant increase in nitrosamines ...

The same day that Valisure announced a “Citizen Petition” with the FDA urging a recall of ranitidine, numerous lawsuits were filed against drug manufacturers.

GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...

Drugmaker Novartis said it is halting distribution of all ranitidine medicines made by Sandoz, a measure it called “precautionary” after the acid-reducing medications were found to contain an ...

In December, a federal judge dismissed 50,000 Zantac cases because the scientific evidence establishing cancer causation didn’t pass legal muster. In March, a California state judge reached the ...